Drug Pricing, Supply Chain Issues May Get House Hearing
Energy & Commerce Health Subcommittee is considering a hearing, but leadership may be concerned Democrats will use the session to air grievances over Republican efforts to repeal the Affordable Care Act.
You may also be interested in...
First hearing in Sen. Alexander's committee was dominated by Democrat complaints about Obamacare repeal; now that there's an actual bill to criticize, the next one might have been even worse, but regardless of the reason, the postponement means innovator prices get to stay out of the spotlight once again.
Energy and Commerce subcommittee unanimously advances reauthorization legislation with four added amendments, including one that would allow for certain generic sponsors to meet early and often with FDA to speed development.
House Oversight Committee’s diatribe against Mylan has been fueled by the company’s efforts to engage lawmakers to advance its business interests, Rep. Mulvaney tells CEO Bresch: 'You asked for it.'